French Banks Stock News

Eurazeo (ENXTPA:RF) has reported a tough FY 2025 picture, with first half revenue of €88.74 million and a basic EPS loss of €4.38, alongside trailing twelve month revenue of €42.71 million and a basic EPS loss of €5.86 that keeps the group firmly in loss-making territory. Over recent periods the company has seen revenue move from €103.81 million in the first half of 2024 to €97.90 million in the second half of 2024 and then to €88.74 million in the first half of 2025. At the same time, basic...

Schneider Electric (ENXTPA:SU) has joined the Thread Group's Board of Directors, taking an active role in shaping the wireless networking standard for smart buildings and energy management. The company has also released research on growing momentum toward autonomous and self optimising operations in the energy and chemicals sector. These developments highlight Schneider Electric's expanding influence in digital infrastructure and industrial automation technologies. For investors tracking...

Tikehau Capital (ENXTPA:TKO) is drawing attention as fund managers highlight its focus on energy transition and energy security assets, particularly manufacturers of critical equipment and local infrastructure solutions that attract capital-intensive clean energy funding. See our latest analysis for Tikehau Capital. The recent focus on energy transition and energy security sits against a mixed performance backdrop, with a 2.9% 7 day share price return, a 16.0% 30 day share price decline, and...

Why LVMH Moët Hennessy Louis Vuitton Société Européenne (ENXTPA:MC) is Back on Investor Radars LVMH Moët Hennessy Louis Vuitton Société Européenne (ENXTPA:MC) is drawing attention after a one-month return of about a 15% decline and a past three-month return near a 27% decline, prompting closer scrutiny of its fundamentals. See our latest analysis for LVMH Moët Hennessy - Louis Vuitton Société Européenne. The recent 27.8% year-to-date share price decline and a weaker one-year total shareholder...

Nanobiotix reported first clinical data from the Johnson & Johnson sponsored Phase 2 CONVERGE trial of JNJ-1900 (NBTXR3) in stage 3 inoperable non small cell lung cancer. Results presented at a major conference showed initial signals of efficacy alongside an acceptable safety profile. The data mark the first readout from a pivotal trial of Nanobiotix’s lead asset in this lung cancer setting. For investors watching ENXTPA:NANO, this update lands after a period of strong share price...

Kekst CNC, a Publicis Groupe subsidiary, has appointed Lyndsey Estin as Co-CEO to lead U.S. operations. The move highlights Publicis Groupe’s focus on advanced communications capabilities in areas such as AI and cybersecurity. For investors tracking ENXTPA:PUB, this shift at Kekst CNC sits squarely in the core of Publicis Groupe’s communications and advisory activities. Kekst CNC is a global communications arm, and its work spans crisis counsel and complex corporate issues that many large...

What Antin’s new buyback program means for shareholders Antin Infrastructure Partners SAS (ENXTPA:ANTIN) has begun a share repurchase program, authorized to buy back up to 10% of its share capital at up to €24 per share over an 18 month period. The €430.06 million program is intended to support liquidity, cover stock option and share based plans, and provide shares for potential transactions or future cancellations, which can affect both ownership structure and per share metrics. See our...

As the European market navigates through the complexities of geopolitical tensions and fluctuating energy prices, indices like the STOXX Europe 600 have shown resilience with a modest advance, reflecting cautious optimism amid ongoing uncertainties. In this context, small-cap stocks often present unique opportunities for investors seeking growth potential in an unpredictable economic landscape. Identifying a good stock in such conditions involves looking for companies with strong fundamentals...

BNP Paribas (ENXTPA:BNP) has launched six crypto-linked exchange-traded notes, expanding its range of digital asset products. The new ETNs are MiFID II regulated and designed with investor protection features for European clients. This move marks a new step in the bank’s approach to bridging traditional banking services with crypto-linked instruments. For a global institution like BNP Paribas, which already operates across retail, corporate and investment banking, adding crypto-linked ETNs...

Leadership change and what it could mean for Ipsos shareholders Ipsos (ENXTPA:IPS) has appointed Alexandre Boissy as Deputy CEO, with global oversight of operations, legal, corporate communications and investor relations. This leadership shift may influence how the group executes and explains its plans. See our latest analysis for Ipsos. Ipsos’s 1-day share price return of 1.7% and modest year to date gain sit against a 1-year total shareholder return decline of 14.3%. Recent momentum is...

In the current European market, investor sentiment is being shaped by geopolitical uncertainties and fluctuating energy prices, with indices like the STOXX Europe 600 showing modest gains amid these challenges. As economic conditions remain unpredictable, growth companies with high insider ownership can offer a unique appeal due to their potential for alignment between management and shareholder interests, which may be particularly valuable in navigating complex market environments.

As European markets navigate the uncertainties brought on by the Middle East conflict and its impact on energy prices, the pan-European STOXX Europe 600 Index has managed a modest advance of 0.35%, reflecting a cautious optimism amid global volatility. With the European Central Bank signaling potential policy adjustments in response to inflationary pressures, investors are keenly observing small-cap opportunities that can weather these macroeconomic challenges while offering growth...

Argan (ENXTPA:ARG) caught investor attention after its annual general meeting approved a 5% dividend increase to €3.45 per share, citing strong 2025 performance, with payment scheduled for April 2, 2026. See our latest analysis for Argan. Despite the AGM news, the share price has fallen, with a 30 day share price return of 16.3% and a year to date share price return of 8.5%. The 1 year total shareholder return is 2.9%, suggesting longer term gains have been modest and recent momentum has...

Index exit puts fresh focus on Wendel’s role in global portfolios Wendel (ENXTPA:MF) has been dropped from the FTSE All-World Index (USD), a change that can prompt rebalancing by index funds and passive investors and draw attention to how the stock now fits into global allocations. See our latest analysis for Wendel. At a share price of €76.25, Wendel’s 1 day and 7 day share price returns of 1.33% and 2.14% come after a 30 day share price return decline of 14.18% and a 1 year total...

If you are wondering whether Sanofi at €81.90 is priced for opportunity or risk, the starting point is understanding what the current share price actually implies about the business. The stock has recently moved 6.6% over the last 7 days, while the 1 year return of a 16.1% decline and a slightly negative year to date result of a 0.5% decline suggest sentiment has been cautious despite a 5 year gain of 18.5%. Recent headlines have focused on Sanofi's position as a major global pharmaceuticals...

DigiKey announced in March 2026 that it had launched an enhanced version of STMicroelectronics’ free eDesignSuite platform, integrating Ultra Librarian’s models, advanced simulation, multi-CAD exports, and direct DigiKey bill-of-materials purchasing for ST components. This deeper tool integration tightens STMicroelectronics’ link to engineers’ everyday workflows, potentially increasing stickiness of its power, signal conditioning and NFC/RFID solutions in a competitive semiconductor...

ABIVAX Société Anonyme (ENXTPA:ABVX) is in focus after full year 2025 earnings showed revenue of €4.57 million and a net loss of €336.1 million, alongside fresh trial, leadership, financing, and index inclusion updates. See our latest analysis for ABIVAX Société Anonyme. The recent earnings release, positive Phase 3 safety update, leadership hires, ESOP related shelf registration, and FTSE All World Index inclusion come against a backdrop of a 1 year total shareholder return above 10x. At the...

Why Compagnie de l'Odet's latest earnings and dividend plans matter Compagnie de l'Odet (ENXTPA:ODET) combined softer full year 2025 results with a proposed higher cash dividend, a mix that gives you fresh information on both business performance and shareholder payout priorities. See our latest analysis for Compagnie de l'Odet. The latest mix of softer 2025 earnings and a higher proposed dividend appears to have supported a short burst of buying interest, with a 7 day share price return of...

Vetoquinol (ENXTPA:VETO) shares are back in focus after the Board approved the 2025 financial statements and announced plans to propose a €0.93 per share dividend to shareholders in May. See our latest analysis for Vetoquinol. That proposed €0.93 dividend comes as the share price, now at €78.9, has seen a 6.9% decline over 1 month and a 6.5% share price return decline year to date. The 1 year total shareholder return is 3%, suggesting recent momentum has softened compared with longer term...

Wondering whether Compagnie Générale des Établissements Michelin Société en commandite par actions is attractively priced or already fully valued? This article walks you through key signals so you can judge the stock's current price with more confidence. The share price recently closed at €28.97, with returns of 1.0% over 7 days, a 15.8% decline over 30 days, a 1.1% gain year to date, and a 7.0% decline over the last year, set against a 15.8% gain over 3 years. Recent coverage has focused on...

ADLPartner (ENXTPA:DKUPL) has set the tone for FY 2025 with first half revenue of €117.4 million and basic EPS of €0.96, alongside trailing twelve month revenue of €230.6 million and EPS of €2.10 that frame how the latest figures sit within the past year’s performance. Over the last three reported halves, revenue has moved from €104.6 million in 1H 2024 to €113.2 million in 2H 2024 and then to €117.4 million in 1H 2025, while basic EPS shifted from €1.40 to €1.14 and then €0.96. This sets up...

If you are wondering whether Airbus is fairly priced or offering value at current levels, it helps to start with how its market performance lines up against underlying worth. The share price recently closed at €159.18, with returns of a 4.3% decline over 7 days, a 13.6% decline over 30 days, a 21.9% decline year to date, and around 0.0% over the last year, compared with 34.1% over 3 years and 69.6% over 5 years. Recent headlines around Airbus have focused on its role as a key aerospace and...

L'Oréal (ENXTPA:OR) has recently drawn investor attention after a one-month return decline of 11.6%, alongside a three-month return decline of 4.3%, prompting closer inspection of its current valuation and fundamentals. See our latest analysis for L'Oréal. At a share price of €351.25, L'Oréal’s recent 1 month share price return of an 11.6% decline contrasts with a positive 1 year total shareholder return of 4.3%. This suggests near term momentum has faded even as longer term holders remain...

Investors may be wondering whether Tikehau Capital at €15.62 is starting to look interesting, or if the market is still pricing in too much risk. The stock has been choppy, with a 1.2% gain over the last 7 days, a 17.4% decline over the past month, and returns of a 1.1% decline year to date and a 14.7% decline over the last year. These moves come as investors reassess listed capital markets groups in general, reacting to shifting views on asset flows, fee sustainability, and balance sheet...